Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Early Phase 1
1(50.0%)
Phase 4
1(50.0%)
2Total
Early Phase 1(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT01719809Terminated

An Evaluation of the Ability to Train Established Glaucoma Patients Who Have Difficulty in Drop Instillation

Role: lead

NCT02642211Early Phase 1Completed

IOP Changes Associated With SICS and Phako

Role: lead

NCT00694876Completed

Impact of Health Literacy and Other Factors on Glaucoma Patient Adherence in South India

Role: lead

NCT00522600Completed

Eye Drop Use in Glaucoma Patients Through Patient Surveys and Video Observations

Role: lead

NCT00750646Unknown

Observational Study of How Patients Take Eye Drops

Role: lead

NCT00329095Phase 4Completed

An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance

Role: lead

All 6 trials loaded